VALEO: A Post Authorization Study, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the Netherlands
Clinical trial NCT00440765 · COMPLETED
Trial details
- NCT number
- NCT00440765
- Sponsor
- Janssen-Cilag B.V.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2004-11-01
- Primary completion
- 2012-01-01
- Enrollment
- 331
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.